Hypok - IRCG

Download Report

Transcript Hypok - IRCG



 Potassium is one of the body's major ions.  Nearly 98% of the body ’ s potassium is intracellular.  The ratio of intracellular to extracellular potassium is important in determining the cellular membrane potential.  Small changes in the extracellular potassium level can have profound effects on the function of the cardiovascular and neuromuscular systems.  The kidney determines potassium homeostasis, and excess potassium is excreted in the urine.


 potassium is necessary for the maintenance of normal charge difference between intracellular and extracellular environments.  potassium homeostasis is tightly regulated by specific ion-exchange pumps (primarily by a cellular, membrane-bound, sodium-potassium ATP-ase).  Derangements of potassium regulation often lead to neuromuscular, gastrointestinal, and cardiac conduction abnormalities.



is defined as a potassium level less than 3.5 mEq/L.

Moderate hypokalemia mEq/L. is a serum level of 2.5-3

Severe hypokalemia than 2.5 mEq/L.

is defined as a level less

The reference range for serum potassium level is 3.5 5 mEq/L


Total body deficit of potassium chronic inadequate intake, long-term diuretic or laxative use, chronic diarrhea, hypomagnesemia & hyperhidrosis Acute potassium depletion diabetic ketoacidosis, severe GI losses : vomiting / diarrhea, dialysis, and diuretic therapy potassium shifts from the EC to IC space Other causes Alkalosis & hypothermia insulin, catecholamines Distal RTA & Bartter syndrome, Periodic hypokalemic paralysis, Hyperaldosteronism & hyperthyroid.

Abnormalities of serum potassium are associated with well described clinical features


S. K+ level

<3.5 mmol/l

Clinical features

Lassitude < 2.5 mmol/l <2 mmol/l Possible muscle necrosis Flaccid paralysis with respiratory compromise Gennari FJ.



N Engl J Med

1998; 339: 451-458

Effects of hypokalemia

  Atrial/ventricular Arrhythmias taking digoxin. are more common in patients with underlying heart disease (especially CAD) and in patients life-threatening Cardiac Arrhythmias is digoxin-toxic. can occur when the serum potassium is very low (< 2 meq/L), or when the serum potassium is relatively low (2 - 3 meq/L) in patients with underlying heart disease, or when the patient

Effects of hypokalemia

  severe (or rapidly occurring) hypokalemia can cause muscle weakness and paralysis exceedingly rare) the paralysis mainly affects the proximal lower extremities => progressing to affect the upper extremities; dysphagia and dysarthria are uncommon and cranial nerve palsies are Rhabdomyolysis can occur in severely potassium-depleted patients - especially following vigorous exercise - and muscle necrosis can rarely occur

Effects of hypokalemia

   hypokalemia produces a due to impaired insulin release and ? impaired insulin resistance) => carbohydrate-intolerance (? worsening hyperglycemia in diabetics.

hypokalemia also produces a metabolic alkalosis stimulation of bicarb absorption by the proximal tubule and ? renal ammoniagenesis) (by ? hypokalemia can contribute to the development, or worsen the symptoms, of hepatic encephalopthy (? due to renal ammoniagenesis)


 Although


changes may be helpful if present, their absence should not be taken as reassurance of normal cardiac conduction. The ECG in hypokalemia may appear normal or may have only subtle findings immediately prior to clinically significant dysrhythmias.  During therapy, monitor for changes associated with over-correction and hyperkalemia including prolonged QRS, peaked T waves, bradyarrhythmia, sinus node dysfunction, and asystole.

The ECG findings in hypokalemia:

Ventricular dysrhythmia, Prolongation of QT interval, ST segment depression, T wave flattening& U waves.


 Drug screen (serum or urine): –


and other sympathomimetic stimulants can cause hypokalemia.

Other drugs include

» » » » »

verapamil overdose.


amphotericin B.



Hormonal assay: • Serum ACTH, • Cortisol, • Renin activity, • Aldosterone

left adrenal adenoma Conn syndrome

2. Replenishing potassium stores

There is no direct correlation between the serum potassium and the total body potassium deficit, but a rough estimate is to assume a total body deficit of ~ 200 - 400 meq of potassium for every 1 meq/L the serum potassium is below 4 meq/L

consider the possibility of associated magnesium deficiency

Replenishing potassium stores

cardiac monitoring

is necessary in patients with   

profound hypokalemia (< 2.5 meq/L), or if cardiac arrhythmias are present, or if IV potassium is going to be rapidly administered.

IV potassium

should normally be diluted in saline solution so that the maximum concentration is 40 meq/L (peripheral lines) or 60 meq/L (central lines) and IV potassium.

IV infusion rate for

severe or symptomatic


 Standard IV replacement rate 10 - 20 meq/h .

 Serum potassium < 2.5 meq/L, or  Moderate-severe symptoms  Serum potassium < 2.0 Meq/L, or  Life-threatening symptoms  If heart block, or  Renal insufficiency exists 20 - 40 meq/h > 40 meq/h 5 - 10 meq/h

Medical Decision-Making and Treatment Transient, asymptomatic, or mild hypokalemia may resolve spontaneously or may be treated with enteral potassium supplements.

Potassium replacement therapy is immediately indicated for:

  


hypokalemia (< 2.5 meq/L), or If the hypokalemia is causing

muscle paralysis

, or Malignant cardiac



Medical Decision-Making and Treatment

 Outpatient therapy and follow-up in 48 - 72 hours may be acceptable for mild hypokalemia patients with no underlying heart disease.

Medical Decision-Making and Treatment

The patient should be transferred to ICU for for: severe or symptomatic hypokalemia  IV potassium supplementation.

 Continuous cardiac monitoring.

Magnesium Replacement Therapy

 Magnesium replacement therapy is often necessary in malnourished alcoholics with hypokalemia.

 Hypomagnesemia should be suspected if the serum potassium does not increase within ~ 96 hours of the commencement of potassium supplementation therapy.

 Magnesium can be given orally (

3g x 4 doses


The cause of hypokalemia

Certain simple combinations of clinical features and abnormal laboratory values could suggest a particular diagnosis


Hypertension + High Serum Renin + High Serum Aldosterone.

1. Renin secreting tumor or 2. Bilateral renal artery stenosis or 3. Malignant hypertension


Hypertension +

Low Serum Renin

+ High Serum Aldosterone.

Primary Hyperaldosteronism


Hypertension + Low Serum Renin + Low Serum Aldosterone


1. Liddle syndrome or 2. congenital adrenal hyperplasia or 3. chronic ingestion of licorice-compounds containing glycyrrhizin or 4. ingestion of other exogenous mineralocorticoids


Hypertension + Normal/high Serum Renin + Normal Serum Aldosterone

Cushing’s Syndrome


Hypotension/normotension + High Serum Renin + High Serum Aldosterone.

“Secondary Hyperaldosteronism”


Normotension + metabolic acidosis + hyperchloremia + urine ph > 6.

Distal RTA



Increased serum renin

Metabolic aklalosis



 Increased urinary chloride (> 100 meq/l)

Bartter's syndrome


Normotension/hypotension + metabolic alkalosis + low urinary chloride

1. Surreptitious vomiting or 2. Prolonged naso-gastric suction and excessive gastric fluid loss

Surgical Care

  Surgical intervention is required only after determining that the etiology requires it.

Etiologies that may require surgery include the following: 1.




Renal artery stenosis.

Adrenal adenoma.

Intestinal obstruction producing massive vomiting.

Villous adenoma.


The following consultations may be appropriate, depending on the clinical findings: 


for evaluation of unexplained urinary potassium losses suggested to be secondary to a tubular disorder.


if Cushing syndrome, primary hyperaldosteronism, glucocorticoid-remediable hypertension, or congenital adrenal hyperplasia is suggested.


for alcoholism or eating disorders 


Diet: ‟

low-sodium and high potassium

The low-sodium diet limits the amount of sodium reabsorbed at the cortical collecting tubule, thus limiting the amount of potassium secreted.

Further Inpatient Care

 Matching potassium intake to losses. 

Monitoring for Hypokalemia or Hyperkalemia Due to Therapy By:


periodic testing of serum potassium levels



 Alleviation of aggravating conditions.

Further Outpatient Care

 Patients should receive follow-up medical care for home management if the condition is expected to persist beyond inpatient care.  Additional medical follow-up must be obtained for associated medical conditions.

Patient Education

 Patients should be educated in terms of predisposing conditions.  The importance and risks involved with potassium supplementation and  The warning signs of hypokalemia or over-treatment must be emphasized in discharge teaching.

 Knowledge of cardiopulmonary resuscitation and education on timely access to emergency medical services may prevent morbidity or mortality.  Ongoing communication is essential in reducing the risks and therapy, especially in patients with chronic conditions associated with hypokalemia.

Medical/Legal Pitfalls

 Failure to adequately communicate the risks of treatment  Failure to appropriately monitor patients receiving potassium supplementation for complications,  Failure to follow serum potassium and other electrolyte concentrations during or after therapy  Treating a patient based on a falsely low serum potassium value due to sampling or lab error